Skip to content

Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases

Seroprevalence of Zoonotic and Arboviral Emerging Infections in Exposed Agents from the City of Montpellier: a Transversal Study.

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06859619
Acronym
SEZAM
Enrollment
183
Registered
2025-03-05
Start date
2025-03-03
Completion date
2025-10-03
Last updated
2025-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brucellosis, Chikungunya Virus Infection, Crimean-Congo Haemorrhagic Fever Virus, Dengue Virus, Hantaviral Infection Nos, Hepatitis E, Leishmaniasis, Leptospirosis, Lyme Disease, Psittacosis, Q Fever, Rickettsiosis, Tick-borne Encephalitis, Toscana Virus, Tularemia, Usutu Virus, West Nile Virus, Zika Virus

Keywords

Leishmaniasis,, Leptospirosis, Brucellosis, Zika virus, Q fever, Rickettsiosis, Lyme disease, Tick-borne encephaliti, Hantavirus, Hepatitis E virus, Dengue virus, Chikungunya virus, West-Nile virus, Usutu virus, Toscana virus, Tularemia, Psittacosis, Crimean-Congo haemorrhagic fever virus, epidemiology

Brief summary

Zoonoses and arboviroses refer to a group of diseases transmitted from animals to humans, either directly or indirectly (via mosquitoes, ticks or contact with contaminated environments). Most of these diseases are found in certain tropical zones, but global warming and increased international trade are modifying their geographical distribution, with a gradual trend towards temperate regions. A number of these pathogens have already been detected in Occitania, including dengue fever, West Nile, leishmaniasis and Q fever. Given the region's high mosquito population and favorable climatic conditions, other zoonoses have a strong potential to appear in the region, or may already be circulating at a low level. The study focuses on 18 pathogens selected for their potential to emerge and establish themselves in the Occitanie region: Leishmaniasis, Leptospirosis, Brucellosis, Q fever, Rickettsiosis, Tularemia, Psittacosis, Lyme disease, Tick-borne encephalitis, Hantavirus, Hepatitis E virus, Dengue virus, Zika virus, Chikungunya virus, West-Nile virus, Usutu virus, Toscana virus, Crimean-Congo haemorrhagic fever virus. The aim of the study is to find out whether patients have antibodies against these infectious agents, which would indicate that they have been exposed to them in the past, even in the absence of symptoms. Describing the circulation of these pathogens will enable to implement appropriate public health measures to avoid the risk of epidemics (mosquito control, informing professionals, etc.), as well as to assess the risk incurred in the workplace and have this risk recognized by the healthcare system.

Detailed description

Current environmental changes are influencing the epidemiology of zoonoses, which account for over 75% of emerging infections, with the Mediterranean region being a high-risk area. The proposed study focuses on occupational zoonoses, that is, those that can be contracted in the workplace, through direct contact with animals or exposure to their environment. Some of these zoonoses are recognized and compensable as occupational diseases (OD), while for others, the onus is on the employee to prove the origin of the contamination. The advantages of studying this population are threefold: i) to document occupational risk and improve management and prevention practices in this context, ii) to use this sentinel population - when many of these zoonoses are emerging - to anticipate risks for the less-exposed general population, iii) in the event of the discovery of a positive serology for an infectious agent considered non-circulating in the Occitanie region, to improve the management of symptomatic patients by raising awareness of differential diagnosis. For the purposes of this study, the zoonoses recognized as occupational diseases are: Mediterranean spotted fever, Lyme borreliosis, tularemia, Q fever, brucellosis, psittacosis, hepatitis E and leptospirosis. Although not recognized as occupational diseases, leishmaniasis, hantaviruses, dengue fever, zika, chikungunya, West Nile virus, Usutu, Toscana, Crimean-Congo hemorrhagic fever and tick-borne encephalitis are of particular interest to workers exposed to these diseases, and are also included in the study. Few data are currently available on the actual rate of circulation of these pathogens in the population of occupationally exposed workers, and none in Occitanie. These outdoor workers also represent a sentinel population, due to their increased exposure, so obtaining precise seroprevalence data in these groups would enable the researchers to anticipate the emergence of these pathogens in the general population in the near future, and to diagnose them individually.

Interventions

Peripheral venous blood sampling for IgG serology against leishmaniasis, leptospirosis, brucellosis, Q fever, rickettsiosis, tularemia, psittacosis, Lyme disease, tick-borne encephalitis, hantavirus, hepatitis E virus, dengue virus, Zika virus, Chikungunya virus, West Nile virus, Usutu virus, Toscana virus, Crimean-Congo hemorrhagic fever virus.

Sponsors

TransVIHMI UM, IRD UMI233, Inserm U1175
CollaboratorUNKNOWN
UMR 1058 Pathogenesis & Control of Chronic & Emerging Infections PCCEI
CollaboratorUNKNOWN
University Hospital, Montpellier
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Intervention model description

cross-sectional study with minimal risk and constraints

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 or over * Consultant in an infectious diseases department * Have given written consent to participate in the study * Working for the City or Metropolis of Montpellier in the Zoo, Espaces Vert or Ecolothèque departments.

Exclusion criteria

* \- Pregnant and breast-feeding women * Persons benefiting from legal protection measures (guardianship, curatorship, safeguard of justice) * Participants who are not fluent in French and who do not have a support person capable of reading French. * Persons unable to express their consent. * Persons participating in another research project with an exclusion period still in progress. * Persons not affiliated to a social security scheme or not benefiting from such a scheme.

Design outcomes

Primary

MeasureTime frameDescription
Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies).Toscana virusBaselineprevalence of pathogen IgG positivity against : Toscana virus
Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies).Crimean-Congo haemorrhagic fever virus.Baselineprevalence of pathogen IgG positivity against : Crimean-Congo haemorrhagic fever virus.
Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies). Leishmaniasis,Baselineprevalence (in percentage) of pathogen IgG positivity against : Leishmaniasis,
Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies).Leptospirosis,Baselineprevalence of pathogen IgG positivity against : Leptospirosis,
Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies).BrucellosisBaselineprevalence of pathogen IgG positivity against : Brucellosis
Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies).Q feverBaselineprevalence of pathogen IgG positivity against : Q fever
Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies).RickettsiosisBaselineprevalence of pathogen IgG positivity against : Rickettsiosis,
Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies).TularemiaBaselineprevalence of pathogen IgG positivity against : Tularemia
Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies).PsittacosisBaselineprevalence of pathogen IgG positivity against : Psittacosis
Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies).Lyme disease,Baselineprevalence of pathogen IgG positivity against : Lyme disease,
Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies).Tick-borne encephalitisBaselineprevalence of pathogen IgG positivity against : Tick-borne encephalitis
Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies).HantavirusBaselineprevalence of pathogen IgG positivity against : Hantavirus
Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies). Hepatitis E virusBaselineprevalence of pathogen IgG positivity against : Hepatitis E virus
Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies).Dengue virusBaselineprevalence of pathogen IgG positivity against : Dengue virus
Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies). Zika virusBaselineprevalence of pathogen IgG positivity against : Zika virus
Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies).Chikungunya virusBaselineprevalence of pathogen IgG positivity against : Chikungunya virus
Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies). West-Nile virus,Baselineprevalence of pathogen IgG positivity against : West-Nile virus,
Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies). usutu virusBaselineprevalence of pathogen IgG positivity against : Usutu virus

Secondary

MeasureTime frameDescription
Determine the specificity of DBS (dried blood spot) serum neutralization for viral serologies. Usutu virusBaselineDetermine the specificity (in percentage) of DBS (dried blood spot) seroneutralization for Usutu virus
Determine the sensitivity of DBS (dried blood spot) serum neutralization for viral serologies. Toscana virusBaselineDetermine the sensitivity (in percentage) of DBS (dried blood spot) seroneutralization for Toscana virus
Determine the factors associated with seropositivity to these diseases. socio-demographic criteriaBaselineOR of logistic regression of univariate model between serologies and socio-demographic criteria (age, sex, profession)
Determine the sensitivity of DBS (dried blood spot) serum neutralization for viral serologies. Crimean-Congo haemorrhagic fever virusBaselineDetermine the sensitivity (in percentage) of DBS (dried blood spot) seroneutralization for Crimean-Congo haemorrhagic fever virus
Determine the specificity of DBS (dried blood spot) serum neutralization for viral serologies. Crimean-Congo haemorrhagic fever virusBaselineDetermine the specificity (in percentage) of DBS (dried blood spot) seroneutralization for Crimean-Congo haemorrhagic fever virus
Determine the specificity of DBS (dried blood spot) serum neutralization for viral serologies. Toscana virusBaselineDetermine the specificity (in percentage) of DBS (dried blood spot) seroneutralization for Toscana virus
Determine the factors associated with seropositivity to these diseases. travel to endemic areasBaselineOR of the logistic regression of the univariate model between serologies and travel to endemic areas for these diseases
Determine the factors associated with seropositivity to these diseases. occupational exposureBaselineOR of the logistic regression of the univariate model between serologies and occupational exposure to these pathologies
Determine the factors associated with seropositivity to these diseases. exposure in private activitiesBaselineOR of the logistic regression of the univariate model between serologies and exposure in private activities, including the importance of contact with transmission vectors,
Determine the factors associated with seropositivity to these diseases. use of mosquito protectionBaselineOR of the logistic regression of the univariate model between serologies and use of mosquito protection,
Determine the factors associated with seropositivity to these diseases.history of transfusion or transplantBaselineOR of the logistic regression of the univariate model between serologies and history of transfusion or transplant
Determine the factors associated with seropositivity to these diseases. comparison of the linear modelsBaselineAOR of the multivariate logistic regression with the best AIC among all the models tested
Estimating vaccination coverage against leptospirosis in the workplaceBaselineprevalence (in percentage) of professional vaccinations for leptospirosis
Estimating vaccination coverage against rabies in the workplaceBaselineprevalence (in percentage) of professional vaccinations for rabies
Determine the sensitivity of DBS (dried blood spot) serum neutralization for viral serologies. Dengue virusBaselineDetermine the sensitivity (in percentage) of DBS (dried blood spot) seroneutralization for Dengue virus
Determine the specificity of DBS (dried blood spot) serum neutralization for viral serologies. Dengue virusBaselineDetermine the specificity (in percentage) of DBS (dried blood spot) seroneutralization for Dengue virus
Determine the specificity of DBS (dried blood spot) serum neutralization for viral serologies. Zika virusBaselineDetermine the specificity (in percentage) of DBS (dried blood spot) seroneutralization for Zika virus
Determine the sensitivity of DBS (dried blood spot) serum neutralization for viral serologies. Zika virusBaselineDetermine the sensitivity (in percentage) of DBS (dried blood spot) seroneutralization for Zika virus
Determine the sensitivity of DBS (dried blood spot) serum neutralization for viral serologies. Chikungunya virusBaselineDetermine the sensitivity (in percentage) of DBS (dried blood spot) seroneutralization for Chikungunya virus
Determine the specificity of DBS (dried blood spot) serum neutralization for viral serologies. Chikungunya virusBaselineDetermine the specificity (in percentage) of DBS (dried blood spot) seroneutralization for Chikungunya virus
Determine the sensitivity of DBS (dried blood spot) serum neutralization for viral serologies. West-Nile virusBaselineDetermine the sensitivity (in percentage) of DBS (dried blood spot) seroneutralization for West-Nile virus
Determine the specificity of DBS (dried blood spot) serum neutralization for viral serologies. West-Nile virusBaselineDetermine the specificity (in percentage) of DBS (dried blood spot) seroneutralization for West-Nile virus
Determine the sensitivity of DBS (dried blood spot) serum neutralization for viral serologies. Usutu virusBaselineDetermine the sensitivity (in percentage) of DBS (dried blood spot) seroneutralization for Usutu virus

Countries

France

Contacts

Primary ContactCHARLOTTE BOULLE, MD
c-boulle@chu-montpellier.fr04 67 33 52 34

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026